1-3 of 3
Guangli Yang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dual Fluorescence Isogenic Synthetic Lethal Kinase Screen and High-Content Secondary Screening for MUC16/CA125-Selective Agents

Thapi D. Rao, Mengyao Xu, Stephanie Eng, Guangli Yang, Robin Manson, Nestor Rosales, Raj Kumar, Irva E. Veillard, Qin Zhou, Alexia Iasonos, Ouathek Ouerfelli, Hakim Djaballah, David R. Spriggs, Oladapo O. Yeku
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (5): 775–785.
https://doi.org/10.1158/1535-7163.MCT-21-0572
Published: 04 May 2022
View article titled, Dual Fluorescence Isogenic Synthetic Lethal Kinase Screen and High-Content Secondary Screening for MUC16/CA125-Selective Agents
Open the PDF for Dual Fluorescence Isogenic Synthetic Lethal Kinase Screen and High-Content Secondary Screening for MUC16/CA125-Selective Agents in another window
Includes: Supplementary data
Journal Articles

CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment

Tomohiro Fujiwara, Mohamed A. Yakoub, Andrew Chandler, Alexander B. Christ, Guangli Yang, Ouathek Ouerfelli, Vinagolu K. Rajasekhar, Aki Yoshida, Hiroya Kondo, Toshiaki Hata, Hiroshi Tazawa, Yildirim Dogan, Malcolm A.S. Moore, Toshiyoshi Fujiwara, Toshifumi Ozaki, Ed Purdue, John H. Healey
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (8): 1388–1399.
https://doi.org/10.1158/1535-7163.MCT-20-0591
Published: 01 August 2021
View article titled, CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
Open the PDF for CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment in another window
Includes: Supplementary data
Journal Articles

A fluorine-labeled methotrexate as a probe for monitoring tumor antifolate pharmacokinetics: Synthesis, in vitro cytotoxicity, and pilot in vivo 19F magnetic resonance spectra

William M. Spees, Guangli Yang, Darren Veach, Maria Belen Rubio, Jason A. Koutcher, William Bornmann
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2003) 2 (10): 933–939.
Published: 24 October 2003
View article titled, A fluorine-labeled methotrexate as a probe for monitoring tumor antifolate pharmacokinetics: Synthesis, <em>in vitro</em> cytotoxicity, and pilot <em>in vivo</em> <sup>19</sup>F magnetic resonance spectra
Open the PDF for A fluorine-labeled methotrexate as a probe for monitoring tumor antifolate pharmacokinetics: Synthesis, <em>in vitro</em> cytotoxicity, and pilot <em>in vivo</em> <sup>19</sup>F magnetic resonance spectra in another window